Related Experiment Video
Updated: Oct 14, 2025

09:22
Fabricating Superhydrophobic Polymeric Materials for Biomedical Applications
Published on: August 28, 2015
19.3K
Biomimetic cellulose-based superabsorbent hydrogels for treating obesity
Marta Madaghiele1, Christian Demitri2, Ivo Surano2
1Department of Engineering for Innovation, University of Salento, Via per Monteroni, 73100, Lecce, Italy. marta.madaghiele@unisalento.it.
Scientific Reports
|November 2, 2021
Summary
A novel cellulose-based superabsorbent hydrogel mimics raw vegetables for obesity treatment. This biomimetic material preserves gut tissue and aids weight management, offering a new mechanobiological therapy.
Area of Science:
- Biomaterials science
- Gastroenterology
- Obesity therapeutics
Background:
- Nutritional and behavioral modifications for obesity are challenging to sustain.
- Vegetable consumption is crucial for diet and nutrient intake.
- There is a need for novel therapeutic approaches for obesity management.
Purpose of the Study:
- To develop and evaluate a novel cellulose-based superabsorbent hydrogel (CB-SAH) as a mechanobiological therapy for obesity.
- To mimic the mechanical properties of raw vegetables for therapeutic applications.
- To assess the impact of CB-SAHs on gut tissue preservation and regulation.
Main Methods:
- Developed a cellulose-based superabsorbent hydrogel (CB-SAH) inspired by raw vegetables.
- Characterized CB-SAH properties in a simulated gastrointestinal environment.
- Investigated gut tissue impact using an ex vivo organ culture (EVOC) model, comparing CB-SAHs to functional fibers and raw vegetables.
Main Results:
- CB-SAHs exhibited significantly higher elasticity than functional fibers, comparable to raw vegetables.
- Biomimetic CB-SAHs demonstrated benefits in preserving and regulating gut tissue within the EVOC model.
- The technology advanced to clinical studies, with a product cleared for weight management aid.
Conclusions:
- Cellulose-based superabsorbent hydrogels offer a promising biomimetic approach for mechanobiological therapy.
- CB-SAHs can effectively preserve and regulate gut tissue, supporting obesity treatment.
- This technology represents a novel, non-systemic oral therapeutic for weight management.

